K252913 is an FDA 510(k) clearance for the Break Wave, a Lithotriptor, Extracorporeal Shock-wave, Urological (Class II — Special Controls, product code LNS), submitted by Sonomotion, Inc. (San Mateo, US). The FDA issued a Cleared decision on January 12, 2026, 122 days after receiving the submission on September 12, 2025. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5990.
| 510(k) Number | K252913 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 12, 2025 |
| Decision Date | January 12, 2026 |
| Days to Decision | 122 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | LNS — Lithotriptor, Extracorporeal Shock-wave, Urological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5990 |